SANA IN A MOTHNLY DEMAND ZONEthe current price is in the monthly demand zone and the stock is expected to start and uptrend soon targeting the quarterly supply zone.Longby majed_3330
This HUGE buy makes me think the stock will go upSANA is very to close to penny stock area, but I think it will go up in medium/long termLongby yurii678221
SANA Ladies and GentlemenThe stock breaks through a resistance level today with supporting volume, weekly oscillators raise their heads Buying - $9.7 First target - $16 Second target - $26 Not a recommendation of course The only way to trade the stock market... continued in the signature below NASDAQ:SANA Longby maor_yehUpdated 1
SANA - two scenarios to evaluateNASDAQ:SANA is offering two potential scenarios. The first is a breakout of a descending trendline after a lengthy consolidation. These are some of my favorite patterns to trade. I'd look to take profits in 3 stages that start with the fib resistance areas and recent highs, and end with anticipation of resistance at the volume weighted average anchored to IPO (purple). I like a tighter stop for the first scenario (~5.70) since biotechs are risky and we're in a month that has a history of seasonal weakness. The second scenario is the potential would be a breakout of a broadening pattern that formed between May and October 2023. Since Jan 10 2024 only wicked through, we'll look for another test and overhead resistance ~7.20 prior to breakout. I will enter on breakout since breakouts from broadening patterns may not retest support. Profit taking would take place at measured ranges from the pattern and key fib levels. Note that the technical projection exceeds 12 month consensus price targets. We also have earnings in March which could be a positive or negative catalyst. A move below ~5.45 would require a new analysis.Longby Ben_1148x2Updated 0
$S AN A is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Sana Biotechnology develops in vivo and ex vivo cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $37.50; stop-loss — $34.00; take-profit — 48.00/MOC price. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.Longby KozakHlibUpdated 3